Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.03 USD | -1.93% | +1.00% | -69.38% |
May. 20 | Aditxt, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 20 | Aditxt, Inc. announced that it has received $0.075135 million in funding | CI |
Business Summary
Number of employees: 47
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immune Reprogramming Technologies
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.90% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | -30.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 61 | 17-09-27 | |
Amro Albanna
CEO | Chief Executive Officer | 54 | 17-09-27 |
Thomas Farley
DFI | Director of Finance/CFO | 51 | 20-09-30 |
Rowena Albanna
COO | Chief Operating Officer | 58 | 20-07-09 |
Jennifer Lee
HRO | Human Resources Officer | - | 20-12-31 |
Dolly B. Tyan
PRN | Corporate Officer/Principal | - | 21-01-28 |
Corporate Officer/Principal | 57 | 20-07-01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Runge
BRD | Director/Board Member | 67 | 20-07-09 |
Amro Albanna
CEO | Chief Executive Officer | 54 | 17-09-27 |
Founder | 61 | 17-09-27 | |
Brian Brady
BRD | Director/Board Member | 46 | 18-11-30 |
Charles Nelson
BRD | Director/Board Member | 71 | Nov. 02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,665,265 | 1,623,757 ( 97.51 %) | 51 ( 0.003063 %) | 97.51 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-69.38% | 3.38M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- ADTX Stock
- Company Aditxt, Inc.